The U.S. Food and Drug Administration (FDA) has awarded a multi-year contract to the Premier healthcare alliance to provide data for post-marketing drug surveillance, supporting the FDA's Office of Surveillance and Epidemiology and the Office of New Drugs, Pediatric and Maternal Health staff in their effort to evaluate drug risks and promote the safer use of prescription drugs by Americans. The FDA has accessed Perspective information relating to inpatient drug use in hospitals since 2001.
FDA access to Premier's Perspective™ database, the largest integrated clinical, financial and operational comparative database in the nation, will complement and strengthen the utility of passive reporting systems currently in place by providing estimates of the number of adult and pediatric patients exposed to drugs nationwide in the inpatient setting. In addition, direct access to the data enhances and accelerates the pace of the FDA's regulatory decision-making process.
Perspective is used by approximately 600 hospitals for benchmarking and quality improvement activities and comprises more than 130 million patient visit records. Hospitals submit data to Premier which validates, analyzes and formats the data to make it meaningful for hospitals.